# A Study to Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic Dermatitis

> **NCT02795832** · PHASE1,PHASE2 · COMPLETED · sponsor: **Ziarco Pharma Ltd** · enrollment: 53 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** ZPL-5212372 1% w/w Ointment BID
- **DRUG:** Placebo Ointment BID

## Key facts

- **NCT ID:** NCT02795832
- **Lead sponsor:** Ziarco Pharma Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2017-03-01
- **Final completion:** 2017-03-01
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2019-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02795832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02795832, "A Study to Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic Dermatitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02795832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*